TrialBMC pharmacology & toxicology2021

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin.

Robert Dobbins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.